Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Lyndsey Runaas MD
Assistant Professor
Department of Medicine
Division of Hematology and Oncology - Medicine

OFFICE ADDRESS:
Froedtert Hospital
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
08/2002 - 05/2006 BA, Ithaca College, Ithaca, NY
08/2006 - 05/2010 MD, University of Wisconsin School of Medicine and Public Health, Madison, WI

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
06/2010 - 06/2013 Residency, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
06/2013 - 06/2014 Chief Resident, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
07/2014 - 06/2017 Fellow, Medicine, Hematology and Oncology, University of Michigan, Ann Arbor, MI

FACULTY APPOINTMENTS:
06/2013 - 06/2014 Vogelman/Carnes Family Endowed Chief Resident, Medicine, Internal Medicine, University of Wisconsin, Madison, WI
08/2017 - 06/2018 Instructor, Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
04/2018 - 09/2020 Assistant Professor, Internal Medicine, Hematology-Oncology, Clement J. Zablocki VA Medical Center, Milwaukee, WI
07/2018 - Present Assistant Professor, Internal Medicine, Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI

CENTER/INSTITUTE AFFILIATIONS:
08/2017 - Present Member, Cancer Center, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
07/01/2019 - 07/01/2021 Associate Program Director, Hematology and Oncology Fellowship, Internal Medicine, Hematology and Oncology
07/01/2021 - Present Program Director, Internal Medicine, Hematology and Oncology, Medical College of Wisconsin

HOSPITAL STAFF PRIVILEGES:
07/2017 - Present Froedtert Hospital, Milwaukee, WI
04/2018 - 09/2020 Clement J. Zablocki VA Medical Center, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Board Certified
Issue DateExpiration
Internal Medicine
08/2013
None
Oncology
10/2017
None
Hematology
10/2017
None
   
Licensure
Number Issue DateExpiration
Wisconsin License
56667-20
2012
10/2025
    

AWARDS AND HONORS:
08/2002 - 05/2006 Park Scholarship, Park Foundation
2009 - Present Inducted into Alpha Omega Alpha
2013 - Present Hematology Opportunities for the Next Generation of Research Scientists (HONORS) Award, American Society of Hematologists

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
2013 - Present American Society of Hematology
2014 - Present American Society of Clinical Oncology
2015 - Present American Society for Blood and Marrow Transplantation

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Ad-Hoc Reviewer
08/2019 Invited abstract reviewer, American Society of Hematology annual meeting
2022 - Present Haematologica
2024 - Present Blood Advances

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
2019 - 2021 Co-Program Director, Planning Committe for Controversies in Hematologic Malignancies Conference

INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
06/2018 - Present Member, BMT CTN 1704 Protocol Committee

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Blockade of IL-23 for the Prevention of Graft Versus Host Disease
Source:
NIH Heart Lung and Blood Institute
Role & Effort:
Co-Investigator
PI:
Dr. William Drobyski
Dates:
09/2018 - Present
  
Pending
Peer Review
Title:
BMT Core - Medical College of Wisconsin
Source:
NIH Cancer Institute
Role & Effort:
Co-Investigator
PI:
Dr. Nirav Shah
  
Prior
Peer Review
Title:
Oligosaccharide supplementation among Clostridium difficile Hematology-Oncology patients
Source:
Advancing Healthy Wisconsin-Research and Education Program
Role & Effort:
Co-Investigator
PI:
Dr. Silvia Munoz-Price
Dates:
07/2019 - 07/2020
Direct Funds:
$50,000
  

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
Treatment of Hematologic Malignancies: Targeted Therapy for Acute Myeloid Leukemia, OncLive State of the Science Summit, Brookfield, WI, 04/08/2019
Updates in AML -- What's new in targeted therapies?, OncLive State of the Science Summit, Milwaukee, WI, 09/20/2023 - Present
 
Regional
Evolving Landscape in AML Treatment: Moving Beyond 3+7?, 7th Annual Controversies in Hematologic Malignancies, Milwaukee, WI, 03/03/2018
Moving Beyond 3+7 in AML: Are we There Yet?, Wisconsin Oncology Network Meeting -- Keynote address, Madison, WI, 03/16/2019
Bone Marrow Transplantation: Risks and Benefits, Aplastic Anemia and MDS International Foundation 2019 Patient & Family Conference, Milwaukee, WI, 07/20/2019 - Present
Acute Leukemia, Leukemia and Lymphoma Society Meeting, 09/21/2019 - Present
Education Track in Cellular Therapy, Midwest Cellular Therapy Conference, Chicago, IL, 04/15/2022 - Present
What's New in MPNs?, 11th Annual Controversies in Hematologic Malignancies, Milwaukee, WI, 05/07/2022 - Present
Hematologic Malignancies and the Palliative Care Physician -- What is the Goal of Care?, 11th Annual Great Lakes Palliative Care Conference, Lake Geneva, WI, 05/2023 - Present
 
Local
Acute Leukemia, Leukemia + Lymphoma Society -- University of Wisconsin Chapter, Virtual, 04/01/2024
 

PEER REVIEWED WORKSHOPS/PRESENTATIONS:
International
Invited poster discussant -- Hematologic Malignancies -- Leukemia, Myelodysplastic Syndromes and Allotransplant., ASCO 2019, Chicago, IL, 06/03/2019
 

COMMITTEE SERVICE:
Medical College of Wisconsin
08/01/2018 - Present Committee Member, Cancer Service Line IT EPIC Provider Stakeholder Group, Hematology and Oncology, Medicine, Medical College of Wisconsin
09/01/2018 - Present Member, Scientific Review Committee, Hematology and Oncology, Medicine
08/01/2019 - 06/30/2020 Member, Medical School Admissions Committee, Medical College of Wisconsin
08/2019 - 09/2023 Committee Member, Graft versus Host Disease Assessment Committee
06/2020 - Present Committee Member, Innovative Therapies Committee, Medical College of Wisconsin
05/2021 - Present Supporting our Staff (SOS) Peer Support Program
 
Hospital
06/14/2019 - Present Committee Member, Accountable Care Team -- 8CFAC, Hematology-Oncology, Internal Medicine, FMLH
 

MCW TEACHING ACTIVITIES:
Medical Student Education
08/2018 - 10/2018 Clinical Faculty for Molecules to Cells Course
03/13/2019 - Present M3 Student Advising
 
Resident and Fellow Education
06/13/2018 - Present Acute Leukemia Talk for PGY1s
03/2021 - Present BMT Talk for Fellows
05/07/2023 Inherited Bone Marrow Failure talk for fellows
07/2023 - Present Introduction to BMT
05/02/2024 Aplastic Anemia talk for fellows
 
Continuing Medical Education
09/11/2017 Hemophagocytic lymphohistiocytosis talk to inpatient advanced practice providers
03/15/2023 - Present Introduction to MDS for the Gyn Onc Faculty
11/15/2023 - Present Introduction to MDS for the Transplant ID faculty
08/23/2024 - Present Basics of GVHD for the transplant ID faculty
10/24/2024 Acute Leukemia Talk for Clinical Research Coordinators
 
Community/Lay Public
03/05/2018 - Present MDS Talk
 

EXTRAMURAL TEACHING:
Resident and Fellow Education
04/2018 - 10/2019 Clement J. Zablocki VA Medical Center, Oversee fellows clinic at VA
06/10/2019 St. Joseph's Hospital, Acute Leukemia Talk for Residents
 

OTHER MENTORING ACTIVITIES:
2021 - 2023 Informally mentored post-doctoral fellow Natalie McAndrew in her submission for a Palliative Care Research Cooperative Group (PCRC) pilot research grant. While this grant was not funded, it helped form the basis of a second grant application -- an RE03 research grant intended to study meaning-centered psychotherapy for family caregivers of hematopoietic stem cell transplant patients.
 

PROGRAMMATIC DEVELOPMENTS:
Educational Programs
Faculty
09/2018 - 06/2019 Participated in a year long program to develop knowledge and skills in curriculum development as part of a peer mentoring program through the department of medicine.
2018 - 2019 Participated in Scholars in Patient Safety and Quality Improvement Program.
05/2022 - 04/2023 Participated in the KINETIC3 teaching academy medical educator track to develop skills in educational scholarship and pedagogy.
 
Research Programs
09/2018 - Present Innovation Fellowship Program: Program designed to foster a culture of innovation throughout the department of medicine and connect the work of Inception Health with our divisions.
 
 
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Runaas L, Hanauer D, Maher M, Bischoff E, Fauer A, Hoang T, Munaco A, Sankaran R, Gupta R, Seyedsalehi S, Cohn A, An L, Tewari M, Choi SW. BMT Roadmap: A User-Centered Design Health Information Technology Tool to Promote Patient-Centered Care in Pediatric Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2017 May;23(5):813-819. PMCID: PMC7293064
2. Magenau J, Runaas L, Reddy P. Advances in understanding the pathogenesis of graft-versus-host disease. Br J Haematol. 2016 Apr;173(2):190-205.
3. Cook RJ, Runaas LN. The Difficulties of Informed Consent in Stem Cell Transplant. Curr Hematol Malig Rep. 2016 Feb;11(1):1-5.
4. Lyndsey Runaas Flora Hoodin Anna Munaco Alex Fauer Roshun Sankaran Tracey Churay Saara Mohammed Sajjad Seyedsalehi Grant Chappell Noelle Carlozzi Michael D. Fetters Rachel Kentor Leah McDiarmid Kristina Brookshire Casiana Warfield Michelle Byrd Sharon Kaziunas Molly Maher John Magenau Larry An Amy Cohn David A. Hanauer Sung Won Choi. Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes JCO Clinical Cancer Informatics. DOI: 10.1200/CCI.17.00110 JCO Clinical Cancer Informatics - published online January 11, 2018.
5. Fauer AJ, Hoodin F, Lalonde L, Errickson J, Runaas L, Churay T, Seyedsalehi S, Warfield C, Chappell G, Brookshire K, Chaar D, Shin JY, Byrd M, Magenau J, Hanauer DA, Choi SW. Impact of a health information technology tool addressing information needs of caregivers of adult and pediatric hematopoietic stem cell transplantation patients. Support Care Cancer. 2019 Jun;27(6):2103-2112. PMCID: PMC6431273
6. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 Apr;25(4):827-833.
7. Runaas L, Hoodin F, Munaco A, Fauer A, Sankaran R, Churay T, Mohammed S, Seyedsalehi S, Chappell G, Carlozzi N, Fetters MD, Kentor R, McDiarmid L, Brookshire K, Warfield C, Byrd M, Kaziunas S, Maher M, Magenau J, An L, Cohn A, Hanauer DA, Choi SW. Novel Health Information Technology Tool Use by Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation: Longitudinal Quantitative and Qualitative Patient-Reported Outcomes. JCO Clin Cancer Inform. 2018 Dec;2:1-12. PMCID: PMC6873938
8. Abedin S, McKenna E, Chhabra S, Pasquini M, Shah NN, Jerkins J, Baim A, Runaas L, Longo W, Drobyski W, Hari PN, Hamadani M. Efficacy, Toxicity, and Infectious Complications in Ruxolitinib-Treated Patients with Corticosteroid-Refractory Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Aug;25(8):1689-1694.
9. Magenau J, Braun T, Gatza E, Churay T, Mazzoli A, Chappell G, Brisson J, Runaas L, Anand S, Ghosh M, Riwes M, Pawarode A, Yanik G, Reddy P, Choi SW. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation. Biol Blood Marrow Transplant. 2019 Aug;25(8):1682-1688.
10. Guru Murthy GS, Szabo A, Michaelis L, Carlson KS, Runaas L, Abedin S, Atallah E. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database. J Natl Compr Canc Netw. 2020 Feb;18(2):169-175.
11. George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase—A real world study Leukemia Research. July 2020;94.
12. Abid MB, Hamadani M, Szabo A, Hari PN, Graham MB, Frank MO, Collier WS, Abedin S, Jerkins JH, Pasquini MC, Runaas L, Shah NN, Chhabra S. Severity of Cytokine Release Syndrome and Its Association with Infections after T Cell-Replete Haploidentical Related Donor Transplantation. Biol Blood Marrow Transplant. 2020 Sep;26(9):1670-1678.
13. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2020 Oct;26(10):1876-1885. PMCID: PMC7571859
14. George G, Rezazadeh A, Zook F, Pearl N, McCoy C, Carlson K, Runaas L, Abedin S, Guru Murthy GS, Michaelis LC, Atallah E, Baumann-Kreuziger L. Reducing venous thrombosis with antithrombin supplementation in patients undergoing treatment for ALL with Peg-asparaginase-A real world study. Leuk Res. 2020 Jul;94:106368.
15. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to ‘Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation’ [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885] (Biology of Blood and Marrow Transplantation (2020) 26/10(1876-1885) (S1083879120304146), (10.1016/j.bbmt.2020.07.005)) Transplantation and Cellular Therapy. 2021.
16. Mohan M, Nagavally S, Shah N NN, Michaelis L, Chhabra S, Souza AD, Abedin S, Runaas L, Guru Murthy GS, Longo W, Hamadani M, Dhakal B, Hari P, Fenske TS. Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies. Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e495-e497. PMCID: PMC8767926
17. Corrao K, Rezwan S, Atallah E, Michaelis LC, Runaas L, Harrington AM, Abedin S. Prognostic impact of immunophenotypic aberrancies of blasts in lower risk myelodysplastic syndrome. Leuk Res Rep. 2022;17:100329. PMCID: PMC9150024
18. Abid MB, Rubin M, Ledeboer N, Szabo A, Longo W, Mohan M, Shah NN, Fenske TS, Abedin S, Runaas L, D'Souza A, Chhabra S, Dhakal B, Hamadani M. Efficacy of a third SARS-CoV-2 mRNA vaccine dose among hematopoietic cell transplantation, CAR T cell, and BiTE recipients. Cancer Cell. 2022 Apr 11;40(4):340-342. PMCID: PMC8864440
19. Chhabra S, Szabo A, Clurman A, McShane K, Waters N, Eastwood D, Samanas L, Fei T, Armijo G, Abedin S, Longo W, Hari P, Hamadani M, Shah NN, Runaas L, Jerkins JH, Van den Brink M, Peled JU, Drobyski WR. Mitigation of gastrointestinal graft-<i>versus</i>-host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination. Haematologica. 2023 Jan 01;108(1):250-256. PMCID: PMC9827178
20. Abedin SM, Badar T, Gauger K, Michaelis LC, Runaas L, Carlson KS, Murthy GG, Atallah E. Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia. Leuk Res. 2022 Dec;123:106984.
21. Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Rizzo JD, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M. Corrigendum to 'Ixazomib for chronic Graft-Versus-Host Disease prophylaxis following allogeneic hematopoietic cell transplantation' [Biology of Blood and Marrow Transplantation 26/10 (2020) 1876-1885]. Transplant Cell Ther. 2022 Oct;28(10):717.
22. Chhabra S, Jerkins JH, Monahan K, Szabo A, Shah NN, Abedin S, Runaas L, Fenske TS, Pasquini MC, Shaw BE, Drobyski WR, Saber W, D'Souza A, Dhakal B, Mohan M, Longo W, Hamadani M. Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2024 Mar;59(3):373-379.
23. Taylor S, Murthy GSG, Runaas L, Michaelis LC, Carlson K, Atallah EL, Abedin SM. Re-induction with venetoclax combinations or IDH inhibitors result in similar remission rates and lower treatment related morbidity among AML patients initially receiving intensive induction chemotherapy. Leuk Res. 2023 Sep;132:107348.
24. Bolaños-Meade J, Hamadani M, Wu J, Al Malki MM, Martens MJ, Runaas L, Elmariah H, Rezvani AR, Gooptu M, Larkin KT, Shaffer BC, El Jurdi N, Loren AW, Solh M, Hall AC, Alousi AM, Jamy OH, Perales MA, Yao JM, Applegate K, Bhatt AS, Kean LS, Efebera YA, Reshef R, Clark W, DiFronzo NL, Leifer E, Horowitz MM, Jones RJ, Holtan SG, BMT CTN 1703 Investigators. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis. N Engl J Med. 2023 Jun 22;388(25):2338-2348. PMCID: PMC10575613
25. Jones MA, Runaas L, Khoriaty RN, Bixby D. Acute Myelogenous Leukemia Oncology Board Review: Blueprint Study Guide and Q&amp;A: Third Edition. 1 January 2021:3-21.
26. Murthy GSG, Saliba AN, Szabo A, Harrington A, Abedin S, Carlson K, Michaelis L, Runaas L, Baim A, Hinman A, Maldonado-Schmidt S, Venkatachalam A, Flatten KS, Peterson KL, Schneider PA, Litzow M, Kaufmann SH, Atallah E. A phase I study of pevonedistat, azacitidine, and venetoclax in patients with relapsed/refractory acute myeloid leukemia. Haematologica. 2024 Sep 01;109(9):2864-2872. PMCID: PMC11367232
27. Furqan F, Bhatlapenumarthi V, Dhakal B, Fenske TS, Farrukh F, Longo W, Akhtar O, D'Souza A, Pasquini M, Guru Murthy GS, Runaas L, Abedin S, Mohan M, Shah NN, Hamadani M. Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood Adv. 2024 Aug 27;8(16):4320-4329. PMCID: PMC11372811
28. Holtan SG, Bolaños-Meade J, Al Malki MM, Wu J, Kitko CL, Reshef R, Rezvani AR, Shaffer BC, Solh MM, Yao JM, Runaas L, Elmariah H, Larkin KT, El Jurdi N, Gooptu M, Loren AW, Hall AC, Alousi AM, Jamy O, Clark W, Kean L, Bhatt AS, Perales MA, Applegate K, Efebera YA, Leifer E, Jones RJ, Horowitz MM, Mattila D, Saber W, Hamadani M, Martens MJ. Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703. J Clin Oncol. 2025 Jan 03:JCO2400921.
 
Books, Chapters, and Reviews
1. Blood and Marrow Transplant Handbook Comprehensive Guide for Patient Care, third edition. Engraftment and Graft Failure. Co-Authors: P Hari, S. Chhaubra